![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
GJ Grover, S Dzwonczyk, PG Sleph and CA Sargent
Department of Pharmacology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey.
Previous studies have indicated that the ATP-sensitive potassium channels blocker glibenclamide (glyburide) can abolish preconditioning in canine models of myocardial ischemia. Recently, an isolated rat heart model of preconditioning has been developed that may be ideal for studying the mechanisms of preconditioning. In the present study, we determined the effect of glyburide on preconditioning in isolated rat hearts. Rat hearts were isolated and retrogradely perfused with oxygenated Krebs'-Henseleit solution. They were then subjected to four periods of total global ischemia of 5-min duration, separated by 5-min reperfusion. The hearts were then subjected to 30-min global ischemia followed by 30-min reperfusion and contractile function and lactate dehydrogenase release determined. Non-preconditioned hearts sustained severe damage. Glyburide (1-100 microM) pretreatment had no effect on the severity of 30-min global ischemia and 30-min reperfusion. Preconditioning caused significant improvements in reperfusion contractile function (25-fold increase in left ventricular developed pressure) and reductions in reperfusion lactate dehydrogenase release and reperfusion end diastolic pressure (contracture). Glyburide had modest preischemic cardiodepressant and vasoconstrictor effects at 1-30 microM, whereas 100 microM caused a 50% reduction in preischemic coronary flow. Despite these effects, none of these concentrations of glyburide affected the efficacy of preconditioning. These studies indicate that preconditioning in isolated rat hearts does not occur via a glyburide- (and thus presumably ATP-sensitive potassium channel) sensitive mechanism.
This article has been cited by other articles:
|
|
 |
|
  M. Fujii and D. J. Chambers Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role? Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 821 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hopper, C. R. Forrest, H. Xu, A. Zhong, W. He, J. Rutka, P. Neligan, and C. Y. Pang Role and mechanism of PKC in ischemic preconditioning of pig skeletal muscle against infarction Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R666 - R676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takeo and Y. Nasa Role of energy metabolism in the preconditioned heart - a possible contribution of mitochondria Cardiovasc Res, July 1, 1999; 43(1): 32 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Takaoka, I. Nakae, K. Mitsunami, T. Yabe, S. Morikawa, T. Inubushi, and M. Kinoshita Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning" J. Am. Coll. Cardiol., February 1, 1999; 33(2): 556 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kouchi, T. Murakami, R. Nawada, M. Akao, and S. Sasayama KATP channels are common mediators of ischemic and calcium preconditioning in rabbits Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1106 - H1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miura, T. Miura, S. Kawamura, M. Goto, J. Sakamoto, A. Tsuchida, M. Matsuzaki, and K. Shimamoto Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes Cardiovasc Res, March 1, 1998; 37(3): 700 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S Carr, R. J Hill, H. Masamune, S. P Kennedy, D. R Knight, W.R. Tracey, and D. M Yellon Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia Cardiovasc Res, October 1, 1997; 36(1): 52 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Piot, D. Padmanaban, P. C. Ursell, R. E. Sievers, and C. L. Wolfe Ischemic Preconditioning Decreases Apoptosis in Rat Hearts In Vivo Circulation, September 2, 1997; 96(5): 1598 - 1604. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. E. Speechly-Dick, G. J. Grover, and D. M. Yellon Does Ischemic Preconditioning in the Human Involve Protein Kinase C and the ATP-Dependent K+ Channel? : Studies of Contractile Function After Simulated Ischemia in an Atrial In Vitro Model Circ. Res., November 1, 1995; 77(5): 1030 - 1035. [Abstract] [Full Text]
|
|
|
|
|
|
K. Hu and S. Nattel Mechanisms of Ischemic Preconditioning in Rat Hearts : Involvement of {alpha}1B-Adrenoceptors, Pertussis Toxin–Sensitive G Proteins, and Protein Kinase C Circulation, October 15, 1995; 92(8): 2259 - 2265. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
